🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Haipeng Xu

Academy of Medical Sciences

ORCID: 0000-0002-6276-0529

Also affiliated with Chinese Academy of Medical Sciences & Peking Union Medical College, Shanghai Chest Hospital, Eye & ENT Hospital of Fudan University, Shanghai Institute of Optics and Fine Mechanics, Shanghai Clinical Research Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents”.

Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents

British Journal of Cancer(2024)10.1038/s41416-024-02760-1
N/A
0DataRank · unranked
13 citations

Valentina Foglizzo, Guilherme Harada, Matteo Repetto, Amanda Kulick, Elisa de Stanchina +17 more